Invion Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVIXF research report →
Price Chart
About the company
Invion Limited, an Australian clinical-stage life sciences enterprise, is actively engaged in the research and development of photodynamic therapy (PDT) to address various cancer types. Its flagship offering, IVX-PDT, is a photosensitizer agent being developed to combat skin cancers alongside a range of solid tumors, including those affecting the lungs, prostate, ovaries, and mesothelioma. The company has forged a research and development alliance with the Hudson Institute of Medical Research, jointly pursuing R&D initiatives for its Photosoft technology across a broad spectrum of cancer treatments.
- CEO
- Thian Chew
- IPO
- 2013
- Employees
- 4
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on IVIXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.08M
- P/E
- -0.54
- PEG
- -0.01
- P/S
- 9.77
- P/B
- 0.63
- EV/EBITDA
- -1.20
- Div Yield
- 0.00%
- Gross Margin
- -347.68%
- Op Margin
- -1472.22%
- Net Margin
- -1464.23%
- ROE
- -102.18%
- ROIC
- -82.47%
Latest fiscal year · YoY change
- Revenue
- $266.14K+0.0%
- Gross Profit
- $-925,303-9.0%
- Op Income
- $-3,918,102
- Net Income
- $-3,896,837+32.8%
- EPS
- $-0.04+46.2%
- OCF Growth
- +16.0%
- FCF Growth
- +15.8%
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 0.40
- RSI (14)
- 100
- Avg Volume
- 1
No earnings-call transcripts are available for IVIXF yet.
- Free Float
- 53.6%
- Shares Outstanding
- 110.55M
- Float Shares
- 59.25M
Our IVIXF coverage
Recent articles, reports, and earnings notes.
No research on IVIXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVIXF report →